Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Shen, Min

Class:IdPerson:6789648
_displayNameShen, Min
_timestamp2015-08-03 15:33:02
created[InstanceEdit:6789598] Jupe, Steve, 2015-08-03
firstnameMin
initialM
surnameShen
(author)[LiteratureReference:6789608] STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1
[LiteratureReference:8940999] Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity
[LiteratureReference:9732886] Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
[LiteratureReference:9766721] Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
[Change default viewing format]
No pathways have been reviewed or authored by Shen, Min (6789648)